KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for Astrana Health (ASTH) over the last 12 years, with Q3 2025 value amounting to $334.0 million.

  • Astrana Health's Other Accumulated Expenses rose 10836.73% to $334.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.0 million, marking a year-over-year increase of 10836.73%. This contributed to the annual value of $209.0 million for FY2024, which is 9599.18% up from last year.
  • Astrana Health's Other Accumulated Expenses amounted to $334.0 million in Q3 2025, which was up 10836.73% from $287.7 million recorded in Q2 2025.
  • Astrana Health's Other Accumulated Expenses' 5-year high stood at $334.0 million during Q3 2025, with a 5-year trough of $42.9 million in Q3 2021.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $100.0 million (2023), whereas its average is $138.5 million.
  • Per our database at Business Quant, Astrana Health's Other Accumulated Expenses surged by 19238.08% in 2024 and then crashed by 2905.55% in 2025.
  • Over the past 5 years, Astrana Health's Other Accumulated Expenses (Quarter) stood at $55.8 million in 2021, then surged by 45.66% to $81.3 million in 2022, then soared by 31.26% to $106.7 million in 2023, then skyrocketed by 95.99% to $209.0 million in 2024, then soared by 59.76% to $334.0 million in 2025.
  • Its Other Accumulated Expenses was $334.0 million in Q3 2025, compared to $287.7 million in Q2 2025 and $204.1 million in Q1 2025.